These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The defective transforming phenotype of c-Jun Ala(63/73) is rescued by mutation of the C-terminal phosphorylation site. Bost F, Caron L, Vial E, Montreau N, Marchetti I, Dejong V, Defize L, Castellazzi M, Binétruy B. Oncogene; 2001 Nov 01; 20(50):7425-9. PubMed ID: 11704873 [Abstract] [Full Text] [Related]
27. Rat embryo fibroblasts transformed by c-Jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors. Kraemer M, Tournaire R, Dejong V, Montreau N, Briane D, Derbin C, Binétruy B. Cell Growth Differ; 1999 Mar 01; 10(3):193-200. PubMed ID: 10099833 [Abstract] [Full Text] [Related]
33. Oncogenic potential of BRAF versus RAS. Benjamin CL, Ananthaswamy HN. Cancer Lett; 2008 Mar 18; 261(2):137-46. PubMed ID: 18280030 [Abstract] [Full Text] [Related]
34. Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts. Schuster R, Gerlich WH, Schaefer S. Oncogene; 2000 Feb 24; 19(9):1173-80. PubMed ID: 10713705 [Abstract] [Full Text] [Related]
35. Lack of c-jun expression in a transformed cell line isolated by glucocorticoid promotion of ras-transfected rat embryo fibroblasts. Marshall H, Popowicz P, Engel G, Martens I, Linder S. Oncogene; 1993 May 24; 8(5):1303-9. PubMed ID: 8479751 [Abstract] [Full Text] [Related]
36. A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs. Zambetti GP, Olson D, Labow M, Levine AJ. Proc Natl Acad Sci U S A; 1992 May 01; 89(9):3952-6. PubMed ID: 1570319 [Abstract] [Full Text] [Related]
37. NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis. Jo H, Zhang R, Zhang H, McKinsey TA, Shao J, Beauchamp RD, Ballard DW, Liang P. Oncogene; 2000 Feb 17; 19(7):841-9. PubMed ID: 10702792 [Abstract] [Full Text] [Related]
38. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene. Rovinski B, Benchimol S. Oncogene; 1988 May 17; 2(5):445-52. PubMed ID: 3287278 [Abstract] [Full Text] [Related]
39. Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation. Wang XJ, Greenhalgh DA, Roop DR. Mol Carcinog; 2000 Mar 17; 27(3):200-9. PubMed ID: 10708482 [Abstract] [Full Text] [Related]
40. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene. Vasseur S, Malicet C, Calvo EL, Labrie C, Berthezene P, Dagorn JC, Iovanna JL. Mol Cancer; 2003 Mar 19; 2():19. PubMed ID: 12685932 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]